Kami Kim, M.D.

Contributing Editor

• Professor of Internal Medicine and Director, Division of Infectious Diseases and International Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida (2017-Present).
• Professor of Medicine, Immunology/Microbiology and Pathology, Albert Einstein College of Medicine, Bronx, New York (2002-2017)
• Director of the NIH-funded Training Program in Geographic Medicine and Emerging Infections, Albert Einstein College of Medicine, Bronx, New York (2013-2017)

Area of Special Interest

• Pathogenesis of toxoplasmosis and malaria, parasitic diseases of global significance. Working with clinical investigators at the Blantyre Malaria Project in Malawi to understand pathogenesis of severe malaria.

Professional Recognitions & Appointments

• National Institutes of Health (NIH-NIAID) National Research Service Award, 1989-1992
• National Institutes of Health (NIH-NIAID) Clinical Investigator Award, 1993-1996
• National Institutes of Health (NIH-NIAID) Independent Scientist Award, 1997-2002
• Burroughs Wellcome Fund New Investigator Award in Molecular Parasitology, 1998-2002
• Burroughs Wellcome Fund New Initiatives in Malaria Research Award, 2001-2003
• Elected Member, American Society for Clinical Investigation
• Elected Member, Association of American Physicians
• Fellow, Infectious Diseases Society of America
• Fellow, American Academy of Microbiology
• Chair, Advisory Committee, Advisory Burroughs Wellcome Postdoctoral Enrichment Program

Publication Highlights

Published over 100 articles in peer reviewed journals including:

• Convalescent Plasmodium falciparum-specific seroreactivity does not correlate with paediatric malaria severity or Plasmodium antigen exposure. Malar Journal - April 2018
• Rapid Diagnostic Testing of Hospitalized Malawian Children Reveals Opportunities for Improved HIV Diagnosis and Treatment. American Journal of Tropical Medicine and Hygiene - December 2017
• Linking EPCR-binding PfEMP-1 to brain swelling in pediatric cerebral malaria. Cell Host & Microbe - October 2017
• Local admixture of amplified and diversified secreted pathogenesis determinants shapes mosaic Toxoplasma gondii genomes. Nature Communications – January 2016
• ELQ-300 prodrugs for enhanced delivery and single-dose cure of malaria. Antimicrobial Agents and Chemotherapy – September 2015
• Inhibition of cytochrome bc1 as a strategy for single-dose, multi-stage antimalarial therapy. American Journal of Tropical Medicine and Hygiene – June 2015

Education

• Harvard University (A.B. Magna Cum Laude)
• Columbia College of Physicians and Surgeons  (Medical School)
• Columbia Presbyterian Medical Center (Residency)
• University of California San Francisco (Fellowship –Division of Infectious Diseases)
• San Francisco General Hospital, UCSF (Post Doctoral Fellowship – Parasitology Laboratory)
• Stanford University School of Medicine (Post Doctoral Fellowship - Department of Microbiology & Immunology)

Disclosures

• Nothing to disclose.